HDFC Defence Fund - Growth Option - Direct Plan vs HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
A side-by-side comparison of returns, cost, size and risk. These funds sit in DIFFERENT categories, so their returns are not directly comparable — they are exposed to different assets and risks.
NAV as of 17 Nov 2026. Returns over 1 year are annualised. Past performance does not indicate future returns, and this comparison is not a recommendation.
| Metric | HDFC Defence Fund | HDFC Pharma and Healthcare Fund |
|---|---|---|
| Category | Thematic Fund | Sectoral/ Thematic |
| Fund house | HDFC Mutual Fund | HDFC Mutual Fund |
| NAV | ₹29.99 | ₹23.411 |
| 1Y return | +11.42% | +15.90% |
| 3Y return | +33.99% | +27.97% |
| 5Y return | — | — |
| AUM | ₹11,493 Cr | ₹3,501 Cr |
| Expense ratio | 0.89% | 1.05% |
| Risk | Very High | Very High |
Highlighting marks the higher return or lower cost on rows where both funds have data. It is arithmetic, not advice — a cheaper or higher-returning fund is not automatically the better choice for you.